Chen Yang
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Ferroptosis and cancer prognosis 15
- Prostate Cancer Treatment and Research 4
- Oncology 22
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Xiangmin Tong (14 shared papers)Xiaolong Liu (1 shared paper)Wei Chen (1 shared paper)Zhongkai Gu (1 shared paper)Xiaomo Wu (1 shared paper)Ao-Xiang Chen (10 shared papers)Yanchun Li (9 shared papers)Zhi‐Ming Shao (8 shared papers)
- Journals
- Breast Cancer Research and Treatment (8 papers)Cell Death and Disease (6 papers)Cancer Cell International (5 papers)Redox Biology (3 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chen Yang
160 papers receiving 4.1k citations
Chen Yang's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 726
- Cancer Research 382
- Pulmonary and Respiratory Medicine 806
- Molecular Biology 1.1k
- Biomaterials 188
Countries citing papers authored by Chen Yang
This map shows the geographic impact of Chen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Yang more than expected).
Fields of papers citing papers by Chen Yang
This network shows the impact of papers produced by Chen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Yang. The network helps show where Chen Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 403 | |
| 2 | Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis Hit paper breakdown → | 2021 | 252 |
| 3 | 2018 | 201 | |
| 4 | 2021 | 155 | |
| 5 | 2022 | 141 | |
| 6 | 2021 | 117 | |
| 7 | 2022 | 114 | |
| 8 | 2023 | 94 | |
| 9 | 2022 | 91 | |
| 10 | 2021 | 90 | |
| 11 | 2011 | 77 | |
| 12 | 2023 | 75 | |
| 13 | 2023 | 71 | |
| 14 | 2017 | 65 | |
| 15 | 2021 | 64 | |
| 16 | 2023 | 63 | |
| 17 | 2016 | 62 | |
| 18 | 2012 | 61 | |
| 19 | Biomaterial-based regenerative therapeutic strategies for spinal cord injury Hit paper breakdown → | 2024 | 57 |
| 20 | 2017 | 54 |
About Chen Yang
Chen Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pharmacology and Cancer Research, having authored 167 papers that have together received 4.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (15 papers), Circular RNAs in diseases (13 papers), Bladder and Urothelial Cancer Treatments (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Genetic Associations and Epidemiology (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Oncology (726 citations), Cancer Research (382 citations), Pulmonary and Respiratory Medicine (806 citations), Molecular Biology (1.1k citations) and Biomaterials (188 citations). Chen Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiangmin Tong, Xiaolong Liu, Wei Chen, Zhongkai Gu, Xiaomo Wu, Ao-Xiang Chen, Yanchun Li, Zhi‐Ming Shao, Jing Du and Xueying Ren. Their work appears in journals such as Breast Cancer Research and Treatment, Cell Death and Disease, Cancer Cell International, Redox Biology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.